检索结果 - Delea, Thomas E

Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma 由 Amdahl, Jordan, Chen, Lei, Delea, Thomas E.

获取全文 获取全文 获取全文

Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzum... 由 Delea, Thomas E., Kartashov, Alex, Sharma, Puza P.

获取全文 获取全文 获取全文

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer 由 Hagiwara, May, Delea, Thomas E., Cong, Ze, Chung, Karen

获取全文 获取全文 获取全文

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2− Advanced Breast Cancer 由 Stellato, Daniel, Thabane, Marroon, Eichten, Caitlin, Delea, Thomas E.

获取全文 获取全文 获取全文

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom 由 Amdahl, Jordan, Diaz, Jose, Sharma, Arati, Park, Jinhee, Chandiwana, David, Delea, Thomas E.

获取全文 获取全文 获取全文

Cost Effectiveness of Labetalol and Propranolol in the Treatment of Hypertension Among Blacks 由 Oster, Gerry, Huse, Daniel M., Delea, Thomas E., Savage, Daniel D., Colditz, Graham A.

获取全文 获取全文

Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor-and HER2-Positive Metastatic Breast Cancer 由 Delea, Thomas E., Hawkes, Carol, Amonkar, Mayur M., Lykopoulos, Konstantinos, Johnston, Stephen R. D.

获取全文 获取全文 获取全文

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia 由 Hatswell, Anthony J., Thompson, Gwilym J., Maroudas, Penny A., Sofrygin, Oleg, Delea, Thomas E.

获取全文 获取全文 获取全文

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease 由 Mallya, Usha G., Boklage, Susan H., Koren, Andrew, Delea, Thomas E., Mullins, C. Daniel

获取全文 获取全文 获取全文

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States 由 Delea, Thomas E., Zhang, Xinke, Amdahl, Jordan, Boyko, Diana, Dirnberger, Franziska, Campioni, Marco, Cong, Ze

获取全文 获取全文 获取全文

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom 由 Amdahl, Jordan, Manson, Stephanie C., Isbell, Robert, Chit, Ayman, Diaz, Jose, Lewis, Lily, Delea, Thomas E.

获取全文 获取全文 获取全文

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada 由 Delea, Thomas E., Weycker, Derek, Atwood, Mark, Neame, Dion, Alvarez, Fabián P., Forget, Evelyn, Langley, Joanne M., Chit, Ayman

获取全文 获取全文 获取全文

Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria 由 Delea, Thomas E., Sofrygin, Oleg, Palmer, James L., Lau, Helen, Munk, Veronica C., Sung, Jennifer, Charney, Alan, Parving, Hans-Henrik, Sullivan, Sean D.

获取全文 获取全文 获取全文

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer 由 Fasching, Peter A, Delea, Thomas E, Lu, Yen-Shen, De Boer, Richard, Hurvitz, Sara A, Moynahan, Aaron, Chandiwana, David, Lanoue, Brad, Hu, Huilin, Thuerigen, Astrid, O’Shaughnessy, Joyce

获取全文 获取全文 获取全文